|
TomoTherapy Inc. and Kirloskar
Partner to Bring State-of-the-Art Cancer Care to India |
|
|
|
|
Partnership agreement inked at ASTRO
Philadelphia. Seen in the photograph are Dr. Fred Robertson, CEO; Ms.
Beth Klein, VP Global Sales; Harry Tschopic, Director Product Mktg.; Ulf
Ahlund, Regional Sales Manager of TomoTherapy Inc. Dr. K.R. Singh, CMD
is accompanied by Ms. Ravi Dara, Executive Director and Amardeep Sethi,
VP Sales & Mktg. |
At the TomoTherapy booth
with Dr. Thomas Rockwell Mackie, Co-founder and Chairman of the Board
TomoTherapy Inc.
Many Indian premiere hospitals were represented by their eminent doctors
who visited the booth and appreciated the TomoTherapy Technology. |
Cancer patients in India
will soon gain access to an advanced technology that allows for greater
accuracy and precision in radiation therapy. TomoTherapy Inc. announced
today that they are teaming up with Kirloskar Theratronics (P) Ltd. (KTPL)
to distribute the TomoTherapy® Hi∙Art System® throughout India and
surrounding countries. KTPL, part of the highly respected Kirloskar Group,
provides radiotherapy equipment and solutions to India, serving about 250
current radiotherapy installations across the country.
KTPL is facilitating installation at Tata
Memorial Centre, which will be the first TomoTherapy Hi∙Art System in
India. The Tata Memorial Centre is a Comprehensive Cancer Care Centre
established in 1941. It is a Grant-in-Aid Institution of India’s Department
of Atomic Energy and remains a pioneer in providing state-of-the-art
treatment options for patients.
Dr. K.A. Dinshaw, the Director of Tata
Memorial Centre, is a recipient of one of the highest civilian awards of
India—Padam Shri. She is also an advisor to the World Health Organization
(WHO). “The concept of radiotherapy treatment using the TomoTherapy
Hi∙Art System is unique,” said Dr. Dinshaw. “The image guidance and 360
degree radiation delivery capabilities of the system provide the opportunity
to treat difficult and select cases, where other treatment devices would
have distinct limitations.”
“The radiotherapy community in India is well
qualified and experienced to learn new technologies such as TomoTherapy,”
added Dr. K.R. Singh, Chairman and Managing Director of Kirloskar. “Cancer
is the second largest cause of death in India. It is estimated that 700,000
to 900,000 new cancer cases will be diagnosed each year. The WHO estimates
that India needs 1000 radiotherapy units to fulfill the future treatment
demand; currently the country has about 400.”
Dr. Fred Robertson, CEO of TomoTherapy Inc.,
said these figures speak to the rapid growth the company is experiencing.
"This is yet another major milestone for TomoTherapy Inc. We're honored to
partner with such respected institutions as Kirloskar and Tata Memorial in
bringing the Hi∙Art System with CTrue™ technology to the people of
India."
The Hi∙Art System will be installed at
Tata Memorial Centre within the next six months.
About TomoTherapy Incorporated
Based in Madison, Wisconsin, TomoTherapy
Incorporated has developed a revolutionary new medical system that
integrates CTrue™ imaging and the helical delivery of conformal radiation
therapy to provide unprecedented accuracy and precision in the treatment of
cancer patients. The TomoTherapy® Hi·Art System® is designed to target
radiation treatment to the patient’s tumor while helping to limit damage to
the surrounding tissues. The technology was developed in collaboration with
the University of Wisconsin.
